Edico Genome, Amazon Web Services Partner
News Dec 01, 2016
Edico Genome has announced that they are deploying DRAGEN on AWS’ newly available Amazon EC2 F1 instances, which are Field Programmable Gate Array (FPGA)-enabled instances in the cloud, potentially reducing analysis times from 26 minutes for a whole genome to real time. “DRAGEN customers appreciate that Edico continues to break new ground to make genomic analysis as rapid as technology allows. With AWS’ newest FPGA-based instances, DRAGEN will be able to analyze whole genomes in almost real time, which is unprecedented and would be a world first,” said Pieter van Rooyen, Ph.D., chief executive officer of Edico Genome.
“We look forward to offering a secure, highly scalable, and cost-efficient platform for genomic analysis to Edico customers, hospitals, academic institutions, drug developers, sequencing centers and others advancing genomic-based work.” A cloud configuration provides users with the flexibility to scale up to the cloud during times of high capacity and return to onsite analysis when demand is reduced.
The platform is compliant with the Health Insurance Portability and Accountability Act, regulations developed by the U.S. Department of Health and Human Services to protect the privacy and security of patients’ health information. Onsite analysis is also feasible, with both systems managed through the DRAGEN web portal, featuring an easy-to-use graphical user interface. Pipelines are identical whether executed in the cloud or onsite.
DRAGEN is highly reconfigurable, using FPGA to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and haplotype variant calling. The flexible DRAGEN platform allows Edico to develop custom algorithms as well as refine and improve existing pipelines.
The following end-to-end, clinical-grade pipelines are currently available on the DRAGEN platform: genome/exome, transcriptome/RNA-seq, epigenome/methyl-seq, metagenome/microbiome, joint genotyping and GATK 3.6. Updated versions are made available for customers through regular, simple remote downloads. Pricing for the DRAGEN cloud solution on AWS will be announced by year end.
Source: Story from Edico Genome. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks' style and length guidelines.
LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target DiscoveryNews
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.READ MORE
Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive CancersNews
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers -- ovarian, prostate and breast.READ MORE
Algorithm Unearths Over 1000 Antibiotic Proteins in a Few HoursNews
The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.READ MORE